LATUDA (lurasidone hydrochloride) Sunovion pharms inc Patent: 9,174,975 Expiration: Aug 20, 2024 See More … For more information on how […]
Source
Drug Patent Expirations for the Week of August 18, 2024 Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
Annual Drug Patent Expirations for LATUDA Latuda is a drug marketed by Sunovion Pharms Inc and is included in one […]
Source
New patent expiration for Sunovion Pharms drug LATUDA Read Post »
This chart shows the pharmaceutical companies with the most patents in Eurasian Patent Organization. Patents must be filed in each […]
Source
Annual Drug Patent Expirations for LIVALO Livalo is a drug marketed by Kowa Co and is included in one NDA. […]
Source
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Spain. SPCs are used in European […]
Source
Which pharmaceutical companies have the most SPCs in Spain? Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
Annual Drug Patent Expirations for ADASUVE Adasuve is a drug marketed by Alexza Pharms and is included in one NDA. […]
Source
New patent expiration for Alexza Pharms drug ADASUVE Read Post »
This chart shows the pharmaceutical companies with the most patents in Netherlands. Patents must be filed in each country (or, […]
Source
Which pharmaceutical companies have the most drug patents in Netherlands? Read Post »